![]() |
市场调查报告书
商品编码
1636721
2030 年氰乙酸乙酯市场预测:按等级、功能、应用和地区进行的全球分析Ethyl Cyanoacetate Market Forecasts to 2030 - Global Analysis By Grade (Pharmaceutical Grade and Industrial Grade), Function (Chemical Intermediates, Polymerization Agents and Catalysts), Application and By Geography |
根据 Stratistics MRC 的数据,2024 年全球氰乙酸乙酯市值为 1.459 亿美元,预计到 2030 年将达到 2.023 亿美元,预测期内的复合年增长率为 5.6%。
氰乙酸乙酯是一种用途广泛的有机化合物,分子式为 C5H7NO2,含有氰基(-CN)和酯基(-COOEt)。它是一种无色黄色液体,具有水果、食用气味,作为生物製药中间体发挥重要作用。氰乙酸乙酯在医药、农业化学品和合成化学品中发挥重要作用,并因其在缩合和聚合反应中的活性而受到重视。
根据1975年至1989年的生产资料,美国氰基丙烯酸酯胶黏剂的工业消费量增加了500%。
药品需求不断成长
氰乙酸乙酯作为药物合成的关键中间体的用途日益广泛,推动了市场的成长。氰乙酸乙酯在抗癌药、抗发炎药、抗病毒药物等药物研发中扮演重要角色。慢性病发病率的上升和製药业的蓬勃发展(尤其是在新兴国家)正在推动需求。此外,化学合成技术的进步提高了生产效率,使得氰乙酸乙酯在药物应用上不可或缺。
原物料价格波动
原物料价格波动对氰乙酸乙酯市场构成重大挑战。乙醇和氰乙酸等基本投入品成本的波动会影响生产成本,并为製造商带来定价不确定性。这种波动会影响利润率并阻碍长期投资。此外,儘管需求不断增长,但替代化学品的竞争增加了价格压力并限制了市场扩张。
个性化医疗的发展
个人化医疗的兴起为氰乙酸乙酯市场提供了重大机会。随着製药公司专注于开发个人化治疗方法,对氰乙酸乙酯等特殊中间体的需求正在增加。氰乙酸乙酯在复杂有机化合物的合成上用途广泛,是製造小众药物的必需原料。这一趋势与生物技术和精准医疗的进步相吻合,为製造商创造了丰厚的成长前景。
健康和安全风险
使用氰乙酸乙酯所带来的健康和安全风险对市场成长构成了突出威胁。由于其毒性,需要严格的处理和储存通讯协定,以防止与接触相关的风险。此外,遵守环境和职业安全标准也增加了营运的复杂性。如果不解决这些风险,可能会导致法律处罚、声誉损害和失去客户信任。
新冠疫情扰乱了全球供应链,暂时减缓了氰乙酸乙酯的生产。然而,疫情期间人们对药品製造的关注度增加,也增加了对其作为药物合成关键中间体的需求。预计医疗保健和农业领域的疫情后復苏努力将维持市场的长期成长。
预计预测期内製药和医疗保健将成为最大的细分市场。
由于氰乙酸乙酯在药物合成中的广泛应用,预计预测期内製药和医疗保健领域将占据最大的市场占有率。氰乙酸乙酯是一种用途广泛的中间体,是製造多种药物(包括抗癌药物和抗病毒药物)的必需原料。全球对创新治疗的需求不断增长,进一步推动了该领域的应用。
预计预测期内工业级部分将以最高的复合年增长率成长。
由于农业化学品、黏合剂和特殊化学品的应用不断增加,工业级部分预计将在预测期内见证最高的复合年增长率。工业级氰乙酸乙酯为大规模生产过程提供了经济高效的解决方案。各行业对高性能材料的需求不断增长,推动了该等级材料的需求并推动了快速增长。
由于亚太地区拥有强大的工业基础设施以及不断扩大的製药和农业化学品行业,预计在预测期内将占据最大的市场占有率。中国和印度等国家凭藉其成本效益高的製造能力和对特种化学品的高需求,在生产和消费方面处于领先地位。该地区强劲的经济成长将进一步推动市场扩张。
由于积极的研发投资以及医药和农业化学品领域的技术进步,预计北美地区在预测期内将实现最高成长率。该地区对永续农业和高品质药品生产的重视正在推动对氰乙酸乙酯作为关键中间体的需求。良好的法律规范进一步增强了成长前景。
According to Stratistics MRC, the Global Ethyl Cyanoacetate Market is accounted for $145.9 million in 2024 and is expected to reach $202.3 million by 2030 growing at a CAGR of 5.6% during the forecast period. Ethyl cyanoacetate is a versatile organic compound with the formula C5H7NO2, characterized by a cyano group (-CN) and an ester group (-COOEt). It is a colorless yellow liquid with a fruity, edible odor, playing an important role as an intermediate in the production of biological products. Ethyl cyanoacetate plays an important role in pharmaceuticals, agricultural chemicals, and synthetics and is valued for its activity in condensation and polymerization reactions.
According to production data between 1975-1989, US industrial consumption of cyanoacrylate adhesives increased 500%.
Growing demand in pharmaceuticals
The increasing use of ethyl cyanoacetate as a key intermediate in pharmaceutical synthesis drives market growth. It plays a crucial role in developing drugs like anti-cancer, anti-inflammatory, and antiviral agents. The rising prevalence of chronic diseases and the growing pharmaceutical industry, especially in emerging economies, are boosting demand. Additionally, advancements in chemical synthesis technologies enhance production efficiency, making ethyl cyanoacetate indispensable for pharmaceutical applications.
Fluctuating raw material prices
Fluctuating raw material prices pose a significant challenge to the ethyl cyanoacetate market. Variability in the cost of essential inputs like ethanol and cyanoacetic acid impacts production costs, creating pricing uncertainties for manufacturers. This volatility affects profit margins and discourages long-term investments. Moreover, competition from alternative chemicals further intensifies pricing pressures, limiting market expansion despite growing demand.
Growth in personalized medicine
The rise of personalized medicine offers significant opportunities for the ethyl cyanoacetate market. As pharmaceutical companies focus on developing tailored treatments, the demand for specialized intermediates like ethyl cyanoacetate is increasing. Its versatility in synthesizing complex organic compounds makes it vital for producing niche drugs. This trend aligns with advancements in biotechnology and precision medicine, creating lucrative growth prospects for manufacturers.
Health and safety risks
Health and safety risks associated with ethyl cyanoacetate usage present a notable threat to market growth. Its toxic nature requires stringent handling and storage protocols to prevent exposure-related hazards. Regulatory compliance with environmental and occupational safety standards adds to operational complexities. Failure to address these risks can result in legal penalties, reputational damage, and loss of customer trust.
The COVID-19 pandemic disrupted global supply chains, temporarily slowing ethyl cyanoacetate production. However, the increased focus on pharmaceutical manufacturing during the pandemic boosted its demand as a key intermediate for drug synthesis. Post-pandemic recovery efforts in healthcare and agriculture are expected to sustain long-term growth for the market.
The pharmaceutical & healthcare segment is expected to be the largest during the forecast period
The pharmaceutical & healthcare segment is expected to account for the largest market share during the forecast period due to its extensive use of ethyl cyanoacetate in drug synthesis. Its role as a versatile intermediate makes it indispensable for producing a wide range of pharmaceuticals, including anti-cancer and antiviral drugs. The growing global demand for innovative treatments further drives adoption in this segment.
The industrial grade segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the industrial grade segment is expected to witness the highest CAGR due to its increasing application in agrochemicals, adhesives, and specialty chemicals. Industrial-grade ethyl cyanoacetate offers cost-effective solutions for large-scale production processes. The rising need for high-performance materials across industries boosts demand for this grade, driving its rapid growth.
The Asia Pacific region is anticipated to account for the largest market share during the forecast period due to its robust industrial infrastructure and expanding pharmaceutical and agrochemical sectors. Countries like China and India lead production and consumption due to their cost-efficient manufacturing capabilities and high demand for specialty chemicals. The region's dynamic economic growth further supports market expansion.
The North America region is anticipated to register the highest growth rate over the forecast period owing to its strong R&D investments and technological advancements in pharmaceuticals and agrochemicals. The region's focus on sustainable farming practices and high-quality drug production drives demand for ethyl cyanoacetate as a critical intermediate. Favorable regulatory frameworks further enhance growth prospects.
Key players in the market
Some of the key players in Ethyl Cyanoacetate Market include Merck KGaA, Shandong Xinhua Pharmaceutical Co., Ltd., Tiande Chemical Holdings Limited, Tokyo Chemical Industry Co., Ltd., HeBei ChengXin, TATEYAMA KASEI Co., Ltd., Triveni Chemicals, EMCO Dyestuff Pvt Ltd, Loba Chemie Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., CDH Fine Chemical, VIVAN Life Sciences, Alfa Chemistry, BOC Sciences, Luxembourg Bio Technologies, Frinton Laboratories, US Biological Life Sciences and VWR International.
In December 2024, Merck, a leading science and technology company announced that it will invest over €70 million to construct a new Advanced Materials Development Center (AMDC) at its Shizuoka site in Japan. This latest investment brings Merck's total investment in the Shizuoka site to over €120 million since 2021, enhancing its existing capabilities in advanced patterning and underscoring the company's dedication to advancing semiconductor technology, expanding research and development capacities, and supporting the growth of the global electronics industry.
In December 2023, BOC Sciences and Spaya have joined forces to expand their chemical offerings, enhancing product diversity and manufacturing capabilities. By joining forces, the two companies create a powerful synergy that exponentially augments the scope and diversity of chemical products available to scientists.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.